High-Avidity CTL Exploit Two Complementary Mechanisms to Provide Better Protection Against Viral Infection Than Low-Avidity CTL
Open Access
- 1 February 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (3) , 1690-1697
- https://doi.org/10.4049/jimmunol.166.3.1690
Abstract
Previously, we observed that high-avidity CTL are much more effective in vivo than low-avidity CTL in elimination of infected cells, but the mechanisms behind their superior activity remained unclear. In this study, we identify two complementary mechanisms: 1) high-avidity CTL lyse infected cells earlier in the course of a viral infection by recognizing lower Ag densities than those distinguished by low-avidity CTL and 2) they initiate lysis of target cells more rapidly at any given Ag density. Alternative mechanisms were excluded, including: 1) the possibility that low-avidity CTL might control virus given more time (virus levels remained as high at 6 days following transfer as at 3 days) and 2) that differences in efficacy might be correlated with homing ability. Furthermore, adoptive transfer of high- and low-avidity CTL into SCID mice demonstrated that transfer of a 10-fold greater amount of low-avidity CTL could only partially compensate for their decreased ability to eliminate infected cells. Thus, we conclude that high-avidity CTL exploit two complementary mechanisms that combine to prevent the spread of virus within the animal: earlier recognition of infected cells when little viral protein has been made and more rapid lysis of infected cells.Keywords
This publication has 40 references indexed in Scilit:
- The Impact of Variation in the Number of CD8+T-Cell Precursors on the Outcome of Virus InfectionCellular Immunology, 1998
- A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitroEuropean Journal of Immunology, 1997
- Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.The Journal of Experimental Medicine, 1996
- Serial triggering of many T-cell receptors by a few peptide–MHC complexesNature, 1995
- Minimal requirements for peptide mediated activation of CD8+ CTLMolecular Immunology, 1994
- Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2JNCI Journal of the National Cancer Institute, 1994
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992
- Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of WashingtonHuman Gene Therapy, 1992
- Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1991
- CYTOTOXIC T CELLS RECOGNIZE VERY EARLY, MINOR CHANGES IN ECTROMELIA VIRUS‐INFECTED TARGET CELLSImmunology & Cell Biology, 1976